Impact of Celebrity, Influencer Drug Product Endorsements to Be Studied by OPDP

Impact of Celebrity, Influencer Drug Product Endorsements to Be Studied by OPDP

How much effect the status of drug product endorsers – be they celebrities, physicians, patients or social media influencers – has on consumers is the subject of a new OPDP study...

 

February 3, 2020 12:30 PM

OPDP To Explore Promotional Implications of Drug Names

OPDP To Explore Promotional Implications of Drug Names

What’s in a name? The FDA’s Office of Prescription Drug Promotion (OPDP) announced a new study last week to answer whether the proprietary name of a prescription drug has an influence...

 

January 27, 2020 12:59 PM

Appeals Court Questions CMS Rule for DTC Ad List Prices

Appeals Court Questions CMS Rule for DTC Ad List Prices

A three-judge panel in the U.S. Court of Appeals for the District of Columbia sounded skeptical of a CMS rule mandating that list prices be included in DTC TV ads for prescription drugs...

January 20, 2020 5:21 PM

Jay Carter Named Chair of Coalition for Healthcare Communication Executive Committee

Jay Carter Named Chair of Coalition for Healthcare Communication Executive Committee

AbelsonTaylor EVP Jay Carter, RPh, has been elected Chair of the Executive Committee of the Coalition for Healthcare Communication for 2020-2021…

January 13, 2020 6:12 PM

Upcoming Event

{title}

{body}

Read More +

About Us

CHC

CHC

The Coalition for Healthcare Communication is an organization that promotes the free exchange of scientific and medical information. It is essential that healthcare professionals and the general public receive truthful, accurate information regarding pharmaceuticals, medical products and devices, and patient care.

In addition to white papers and other documents published by the Coalition, you can also find relevant information on current healthcare and health economics issues, as well as policy positions published by government agencies and other professional organizations.